Novartis receives approval from the European Commission for Tabrecta for the treatment of non-small cell lung cancer
The European Commission has opened an antitrust investigation into whether the Swiss drug company Vifor Pharma restricted competition […]
The impact of changes in the microbiome, particularly the gut microbiome, on a variety of health conditions is […]
The MS Society responds as MS therapy Fampyra is rejected
Updated Date: Tue, 14 Jun 2022 00:00:00 EDT
COVID-19 rebound following Paxlovid treatment likely due to insufficient drug exposure, researchers find after showing rebound patient did […]
European countries could significantly reduce the health harms caused by alcohol consumption by introducing minimum pricing for alcoholic […]
Eplontersen significantly improved patient-reported quality of life following successful research
Oliver highlights several important matters relating to access to rehabilitation services.1 As he points out, there can be […]
The experience of the covid-19 pandemic will inevitably prompt investigators to propose viral causes for the extensive and […]